3 Firms Lead French Pharma Biz's $952M Biotech Co. Deal
French pharmaceutical company Ipsen on Monday said it has agreed to acquire biotechnology company Albireo Pharma for approximately $952 million in a deal guided by Paul Weiss Rifkind Wharton & Garrison...To view the full article, register now.
Already a subscriber? Click here to view full article